Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-10-04A Randomized, Double-Blind, Parallel-Group, Comparative Study of Flexible Doses of Paliperidone Palmitate and Flexible Doses of Risperidone Long-Acting Intramuscular Injection in Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2011-09-20PHARMACOLOGICAL TREATMENT OF COGNITIVE DEFICITS IN SCHIZOPHRENIC PATIENTS: The Effects of Central Cholinergic Augmentation on Cognitive Deficits and Psychopathology
-
CLINICAL_TRIALS study record update · 2011-09-19Effects of Classical and Atypical Antipsychotics on Dopamine Receptor Binding of 123I-epidepride, Cognition, Startle Response and Extrapyramidal Side-effects in Drug-naive First-episode Schizophrenic Patients
-
CLINICAL_TRIALS study record update · 2011-09-195-HT2A-receptor Binding: Implications for the Pathophysiology of Schizophrenia and Effects of Treatment With Antipsychotic Drugs
-
CLINICAL_TRIALS study record update · 2011-09-08A Phase 1, Open-Label, Drug-Drug Interaction Study to Determine the Effect of Repeated Dose Lurasidone 120 mg Administration on the Pharmacokinetics of Orally Administered Digoxin 0.25 mg in Patients With Schizophrenia or Schizoaffective Disorder.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-09-08AN OPEN-LABEL, RANDOMIZED, THREE-PERIOD, TWO-SEQUENCE CROSSOVER, REPEATED-DOSE, REPLICATE DESIGN STUDY TO DETERMINE THE BIOEQUIVALENCE OF TWO DIFFERENT LURASIDONE FORMULATIONS IN PATIENTS WITH SCHIZOPHRENIA, SCHIZOAFFECTIVE, OR SCHIZOPHRENIFORM DISORDER
-
CLINICAL_TRIALS study record update · 2011-09-08A Phase 1, Open-Label, 2-Period, Sequential, Drug-Drug Interaction Study To Determine The Effect Of Lithium 600 Mg BID On The Safety And Pharmacokinetics Of Lurasidone 120 Mg QD In Patients With Schizophrenia Or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2011-09-07Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia. (BMS)
-
CLINICAL_TRIALS study record update · 2011-09-07Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia, (SFBRI).
-
CLINICAL_TRIALS study record update · 2011-09-02Seroquel Safety Study
-
CLINICAL_TRIALS study record update · 2011-08-19Phase IV Study of Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS)
-
CLINICAL_TRIALS study record update · 2011-08-18Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2011-08-04Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications
-
CLINICAL_TRIALS study record update · 2011-08-02Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Essential Fatty Acid Deficiency Replacement in Early Schizophrenia
-
CLINICAL_TRIALS study record update · 2011-08-01Sertindole Versus Risperidone Safety Outcome Study: a Randomised, Partially-blinded, Parallel-group, Active-controlled, Post-marketing Study
-
CLINICAL_TRIALS study record update · 2011-07-29The Effects of Ziprasidone 320 mg on Glucose and Plasma Lipids in Patients With Diabetes Type II and Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2011-07-28Transcranial Magnetic Stimulation Used to Treat Auditory Hallucinations in Schizophrenia
-
CLINICAL_TRIALS study record update · 2011-07-25Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients: Analysis for Three Drugs, Olanzapine, Risperidone, and Aripiprazole, Known to Induce Different Degrees of Weight Gain
-
CLINICAL_TRIALS study record update · 2011-07-25Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and Fluvoxamine
-
CLINICAL_TRIALS study record update · 2011-07-25Independent Investigator Grant Study-Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism
-
CLINICAL_TRIALS study record update · 2011-07-21A 16-Week, Randomized, Controlled Trial of the Effect of Aripiprazole Versus Standard of Care on Non-HDL Cholesterol Among Patients With Schizophrenia and Bipolar I Disorder Who Have Pre-existing Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2011-07-13A Multicenter, Open Label, Flexible-dose, Parallel-group Evaluation of the Cataractogenic Potential of Quetiapine Fumarate (Seroquel) and Risperidone (Risperdal) in the Long Term Treatment of Participants With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2011-07-08ClinicalTrials.gov study NCT01389908
-
CLINICAL_TRIALS study record update · 2011-06-29A Placebo-Controlled Single-Dose Trial of Sildenafil in Schizophrenia
-
CLINICAL_TRIALS study record update · 2011-06-28The Purpose of the Study is to Gain an In-depth Picture of the Patient Management and Prescription Behaviours